Edap TMS SA (EDAP)
7.11
+0.07
(+0.99%)
USD |
NASDAQ |
May 01, 16:00
7.11
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Revenue (Quarterly): 21.12M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.12M |
| September 30, 2023 | 12.78M |
| June 30, 2023 | 15.57M |
| March 31, 2023 | 15.89M |
| December 31, 2022 | 16.07M |
| September 30, 2022 | 12.33M |
| June 30, 2022 | 15.07M |
| March 31, 2022 | 14.59M |
| December 31, 2021 | 15.98M |
| September 30, 2021 | 11.13M |
| June 30, 2021 | 12.47M |
| March 31, 2021 | 12.41M |
| December 31, 2020 | 18.32M |
| September 30, 2020 | 11.03M |
| June 30, 2020 | 10.19M |
| March 31, 2020 | 8.398M |
| December 31, 2019 | 13.27M |
| September 30, 2019 | 11.46M |
| June 30, 2019 | 14.03M |
| March 31, 2019 | 11.51M |
| December 31, 2018 | 9.478M |
| September 30, 2018 | 30.11M |
| June 30, 2018 | 10.27M |
| March 31, 2018 | 11.25M |
| December 31, 2017 | 12.51M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.376M |
| June 30, 2017 | 10.25M |
| March 31, 2017 | 9.241M |
| December 31, 2016 | 11.54M |
| September 30, 2016 | 8.920M |
| June 30, 2016 | 9.261M |
| March 31, 2016 | 9.628M |
| December 31, 2015 | 12.90M |
| September 30, 2015 | 7.120M |
| June 30, 2015 | 8.660M |
| March 31, 2015 | 7.015M |
| December 31, 2014 | 8.090M |
| September 30, 2014 | 9.159M |
| June 30, 2014 | 7.725M |
| March 31, 2014 | 10.64M |
| December 31, 2013 | 11.01M |
| September 30, 2013 | 7.374M |
| June 30, 2013 | 5.880M |
| March 31, 2013 | 7.824M |
| December 31, 2012 | 12.22M |
| September 30, 2012 | 7.098M |
| June 30, 2012 | 7.865M |
| March 31, 2012 | 6.343M |
| December 31, 2011 | 10.14M |
| September 30, 2011 | 8.647M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.398M
Minimum
Mar 2020
21.12M
Maximum
Dec 2023
13.80M
Average
13.27M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Biophytis SA | -- |
| Cellectis SA | 0.155M |
| Genfit SA | 15.36M |
| Adaptimmune Therapeutics PLC | 0.231M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.431M |
| Total Expenses (Quarterly) | 24.87M |
| EPS Diluted (Quarterly) | -0.14 |
| Enterprise Value | 219.81M |
| Gross Profit Margin (Quarterly) | 43.65% |
| Profit Margin (Quarterly) | -25.71% |
| Earnings Yield | -8.67% |
| Normalized Earnings Yield | -8.119 |